LUNDBECK PHARMA A/S
CVR 56750215 · Public limited company (A/S) · Active · Low risk
LUNDBECK PHARMA A/S is a Public limited company (A/S), founded on , based in Valby. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 3.4m and a net result of DKK 2.3m.
Bankruptcy risk for LUNDBECK PHARMA A/S
0.0 × the average (1.41%) · higher risk than 6% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 56750215
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (68 years)
- Address
- Ottiliavej 9
2500 Valby - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 500k
- Employees
- 17 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 31 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 17.3% |
| Current ratio | 120% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 6 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 9 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | DKK 18.9m | DKK 18.3m | DKK 16.0m |
| Gross profit | DKK 4.3m | DKK 1.9m | DKK 2.6m |
| Net profit | DKK 2.3m | DKK 1.8m | DKK 991k |
| Equity | DKK 3.4m | DKK 3.5m | DKK 2.5m |
| Total assets | DKK 19.5m | DKK 19.6m | DKK 16.7m |
| Short-term debt | DKK 16.1m | DKK 16.1m | – |
| Avg. employees | 18 | 20 | – |
Latest annual report: Reporting class B · auditor's statement: Auditor's report on audited financial statements · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 78 | ||
| 1 Jan 2024 – 31 Dec 2024 | 86 | ||
| 1 Jan 2023 – 31 Dec 2023 | 82 | ||
| 1 Jan 2022 – 31 Dec 2022 | 81 | ||
| 1 Jan 2021 – 31 Dec 2021 | 82 | ||
| 1 Jan 2020 – 31 Dec 2020 | 103 | ||
| 1 Jan 2019 – 31 Dec 2019 | 85 | Restated | |
| 1 Jan 2018 – 31 Dec 2018 | 81 | ||
| 1 Jan 2017 – 31 Dec 2017 | 116 | ||
| 1 Jan 2016 – 31 Dec 2016 | 97 | ||
| 1 Jan 2015 – 31 Dec 2015 | 130 | ||
| 1 Jan 2014 – 31 Dec 2014 | 113 | ||
| 1 Jan 2013 – 31 Dec 2013 | 104 | ||
| 1 Jan 2012 – 31 Dec 2012 | 120 | ||
| 1 Jan 2011 – 31 Dec 2011 | 170 | ||
| 1 Jan 2010 – 31 Dec 2010 | 101 | ||
| 1 Jan 2009 – 31 Dec 2009 | 118 | ||
| 1 Jan 2008 – 31 Dec 2008 | 141 | ||
| 1 Jan 2007 – 31 Dec 2007 | 148 | ||
| 1 Jan 2006 – 31 Dec 2006 | 151 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Flemming Juul Jensen | ||
| CEO | Harald Conradi-Larsen | ||
| CEO | H. LUNDBECK A/S | ||
| CEO | Rolf Gunnar Gisel-Ekdahl | ||
| CEO | Christoffer Dahl | ||
| Board | Michala Fischer-Hansen | Current | |
| Board | Søren Klein-Kristensen | Current | |
| Board | Thomas Bo Bjørn Klee | Current | |
| Board | Carl-Emil Ramm Sandberg | ||
| Board | Mogens Franck Gustav Ekström | ||
| Board | Flemming Juul Jensen | ||
| Board | Ib Dybdahl Christoffersen | ||
| Board | Erik Sprunk-Jansen | ||
| Board | Arne Villy Jensen | ||
| Board | Haldor Christensen | ||
| Board | Søren Hjuler Vogelsang | ||
| Board | Olaf Thrane | ||
| Board | Kurt Kruhøffer | ||
| Board | Anne-Grethe Laursen | ||
| Board | Eva Steiness | ||
| Board | Rolf Gunnar Gisel-Ekdahl | ||
| Board | Harald Conradi-Larsen | ||
| Board | Ole Steen Antonsen | ||
| Board | Søren Hjuler Vogelsang | ||
| Board | Erik Sprunk-Jansen | ||
| Board | Eva Steiness | ||
| Board | Rolf Gunnar Gisel-Ekdahl | ||
| Board | Flemming Juul Jensen | ||
| Board | Harald Conradi-Larsen | ||
| Board | Hans Henrik Munch-Jensen | ||
| Board | Lars Bang | ||
| Board | Stig Eilert Paulsen | ||
| Board | Jarl Håkan Kotka | ||
| Board | Jens Gaardbo | ||
| Board | Marianne Vinther | ||
| Board | Ole Chrintz | ||
| Board | Staffan Schüberg | ||
| Board | Stig Løkke Pedersen | ||
| Board | Erik Allikmets | ||
| Board | Ole Chrintz | ||
| Board | Cornelia Brigitte Bolz | ||
| Board | Michael Quiqueran-Beaujeu | ||
| Board | Leif-Petter Jokinen | ||
| Board | Thomas Bo Bjørn Klee | ||
| Board | Joao Carlos Nunes Rocha | ||
| Board | Adrianus Marinus van der Vliet | ||
| Board | Christoffer Dahl | ||
| Board | Joao Carlos Nunes Rocha | ||
| Board | Staffan Schüberg | ||
| Board | Jacob Tolstrup | ||
| Board | Thomas Bo Bjørn Klee | ||
| Board | Dierk Erwin Schoch | ||
| Board | Ole Wendler Pedersen | ||
| Board | Johannes Michael Leuchs | ||
| Owner (100%) | H. LUNDBECK A/S | Current | |
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | Martin Vilhelm Lind | ||
| Auditor | Søren Bjerre-Nielsen | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB |
The CEOs' other companies
Flemming Juul Jensen – 9 other companies, of which 2 bankrupt
- BIO TAP A/S Bankrupt 29 Jun 2017
- Neonatal Baby Care ApS Bankrupt 12 Aug 2022
- A/S LUNDBECK MIDDLE EAST Fusioneret
- AKTIESELSKABET AF 20.NOVEMBER 2003 Active
- H. LUNDBECK A/S Active
- MEDIMERC A/S Opløst
- ORIGIO A/S Active
- TUNSTALL A/S Active
- TUNSTALL HOLDING DANMARK A/S Fusioneret
Harald Conradi-Larsen – 4 other companies
- A/S LUNDBECK MIDDLE EAST Fusioneret
- LUNDBECK MIDDLE EAST A/S Fusioneret
- MEDIMERC A/S Opløst
- NA AF 8 4 2008 A/S Opløst
Christoffer Dahl – 2 other companies
Address history (1 moves)
| Ottiliavej 9, 2500 Valby | |
| Dalbergstrøget 5, 2630 Taastrup |
Former names
| LUNDBECK PHARMA A/S | – now |
| HANS LUNDBECK A/S | – |
Employees per year
Other companies at the same address
- Embark Holdings ApS Active
- Embark Laboratories ApS Active
- H. LUNDBECK A/S Active
- Incipiam Pharma ApS Active
- LUNDBECK CHINA HOLDING A/S Opløst
- LUNDBECK COGNITIVE THERAPEUTICS A/S Fusioneret
- LUNDBECK EXPORT A/S Active
- LUNDBECK INS A/S Opløst
- LUNDBECK MIDDLE EAST A/S Fusioneret
Similar companies in København
- ALFASCAN ApS København K
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
- Venteus Medical Devices (US) ApS København Ø
Questions and answers about LUNDBECK PHARMA A/S
Has LUNDBECK PHARMA A/S gone bankrupt?
No, LUNDBECK PHARMA A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of LUNDBECK PHARMA A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the auditor of LUNDBECK PHARMA A/S?
LUNDBECK PHARMA A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was LUNDBECK PHARMA A/S founded?
LUNDBECK PHARMA A/S was founded on 24 February 1958.
What is the equity of LUNDBECK PHARMA A/S?
Equity was DKK 3.4m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.